Juncture Wealth Strategies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Sell
11,625
-240
-2% -$23.2K 0.33% 59
2026
Q2
$929K Buy
11,865
+1,184
+11% +$80.7K 0.24% 67
2026
Q1
$690K Sell
10,681
-294
-3% -$20.7K 0.23% 65
2025
Q4
$739K Sell
10,975
-139
-1% -$9.35K 0.24% 58
2025
Q3
$815K Buy
11,114
+580
+6% +$38.5K 0.27% 53
2025
Q2
$548K Sell
10,534
-1,851
-15% -$105K 0.19% 64
2025
Q1
$790K Buy
12,385
+407
+3% +$23.6K 0.31% 56
2024
Q4
$573K Sell
11,978
-80
-0.7% -$4.1K 0.21% 65
2024
Q3
$690K Buy
12,058
+415
+4% +$23.8K 0.27% 60
2024
Q2
$610K Buy
11,643
+4,184
+56% +$183K 0.26% 55
2024
Q1
$303K Buy
+7,459
New +$280K 0.13% 86

Other funds holding HALO

Juncture Wealth Strategies's HALO Position: Q3 2026 in Review

Juncture Wealth Strategies reduced its Halozyme (HALO) stake by 2% in Q3 2026, selling an estimated $23.2K and leaving 11,625 shares worth $1.28M. The position accounts for 0.33% of the portfolio, ranked #59.

Juncture Wealth Strategies first reported a position in HALO in Q1 2024 and has held it in 11 quarters since. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Juncture Wealth Strategies held 11,625 shares of Halozyme worth $1.28M as of Q3 2026.
  • Juncture Wealth Strategies sold 240 Halozyme shares in Q3 2026, an estimated $23.2K.
  • Halozyme made up 0.33% of Juncture Wealth Strategies's portfolio in Q3 2026, its #59 holding.
  • Juncture Wealth Strategies first reported a position in Halozyme in Q1 2024 and has held it in 11 quarters since.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Juncture Wealth Strategies's 13F filing for Q3 2026, filed 6 Oct 2026.